tirzepatide type 1 diabetes trial cuts risk of by 94% in adults with prediabetes and obesity or overweight, drugmaker says Tirzepatide: First Approval | Drugs

The Nutrition and Healthy Aging study investigated this effect in humans, and while a 16:8 approach did result in reductions in insulin resistance, the results were not significantly different from the control group

Activation of hypoxia-inducible factor-1 via prolyl-4 hydoxylase-2 gene silencing attenuates acute inflammatory responses in postischemic myocardium

Clinical Efficacy of Mounjaro The studies done on Mounjaro also highlight its metabolic impact with lower HbA1c thereby putting the patient on a regimen to address diabetes and obesity if the patient has type 2 diabetes

Weight loss science and solutions are changing, Spector said